0001675644-26-000023
SEC filingFVCBankcorp, Inc. reported strong FY 2025 performance with total assets reaching $2.29 billion, up $93.3 million or 4% from $2.20 billion in 2024. Loans grew 4% to $1.941 billion, driven by 35% increase in commercial and industrial loans to $453.4 million. Deposits expanded 7% to $1.997 billion, with core deposits up 6%. Net income surged 46% to $22.1 million from $15.1 million, fueled by 15% higher net interest income at $63.8 million and 44% rise in noninterest income to $3.6 million. Net interest margin improved to 2.92% from 2.62%, aided by lower deposit costs. Provision for credit losses was $1.6 million versus negligible $6 thousand prior year, reflecting loan growth. Noninterest expense increased 5% to $37.6 million, mainly salaries. Asset quality remained solid with nonperforming loans at 0.55% of total loans, down from 0.69%. Return on average assets rose to 0.99% from 0.69%. These results underscore resilient growth in a high-rate environment, supported by relationship banking in Washington D.C. and Baltimore MSAs, positioning FVCB for continued expansion amid economic challenges.
FVCBankcorp delivered robust FY 2025 results, with net income of $22.1 million, up 46% from $15.1 million in 2024. Total assets grew to $2.29 billion (+4%), loans to $1.941 billion (+4%), and deposits to $1.997 billion (+7%). Net interest income rose 15% to $63.8 million, boosted by higher loan yields (5.85% vs 5.71%) and lower funding costs (3.42% vs 3.71%). Noninterest income increased 44% to $3.6 million, led by $1.2 million from ACM equity interest. Expenses edged up 5% to $37.6 million, primarily salaries. ROAA improved to 0.99% from 0.69%, NIM to 2.92% from 2.62%.
Revenue, defined as net interest income plus noninterest income, reached $67.4 million, up 16% YoY. Net interest income grew on 3% higher average earning assets ($2.18B) and 9 bps yield increase to 5.43%. Loan interest dominated at $108.9 million. Noninterest income surged on ACM ($1.2M vs $0.4M), service charges ($1.2M), and other fees. No geographic or product segments detailed beyond CRE (53% of loans) and C&I (23%). Growth tied to organic expansion in D.C./Baltimore MSAs.
NIM expanded 30 bps to 2.92% via deposit repricing amid Fed cuts. Provision $1.6M reflected loan growth; ACL steady at 0.97% of loans. Efficiency ratio improved to 55.74% from 61.63%. ROAE rose to 8.99% from 6.64%. Costs controlled despite 7% salary hike.
Operating cash flow $23.9M. Investing used $94.7M net on loans; financing provided $68.3M from deposits. Liquidity strong at 12% of assets. Equity $253.6M (11.1% of assets); well-capitalized (Tier 1 14.37%). CRE concentration 313% of risk-based capital managed prudently.
Organic growth via relationships, selective branching/acquisitions targeted. Resiliency noted amid mild recession, high rates. Risks: CRE exposure, government contractor reliance (45% C&I), cannabis banking (10% loans). Strong underwriting, monitoring emphasized.